Recombinant human interferon α2b for injection

This product has the effects of broad-spectrum antiviral, inhibiting tumor cell proliferation and improving immune function. Improving immune function includes enhancing the phagocytic effect of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

Main ingredients: recombinant human interferon alpha; 2b, human serum albumin.

This product is a yellowish or white loose body. After dissolving, it becomes a clear liquid with no insoluble matter visible to the naked eye.

It can be used to treat acute and chronic viral hepatitis (type B, type C, etc.), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.

This product can be injected intramuscularly, subcutaneously and intralesionally. Use after completely dissolving with 1-2ml sterile water for injection. 1 Chronic hepatitis B: The recommended dose is 3-5 million international units (IU) each time, injected once a day or every other day, and a course of treatment of 3-6 months. The doctor can adjust the dose according to the specific situation of the patient. 2 Chronic hepatitis C: The recommended dose is 3-5 million international units (IU) each time, injected once a day or every other day, and a course of treatment of 3-6 months. The doctor can adjust the dose according to the specific situation of the patient. 3 Genital warts: The recommended dose is 1-3 million international units (IU) each time, injected three times every other day per week, and a course of treatment of 1-2 months. 4 Hairy cell leukemia: The recommended dose is 3 million international units (IU) each time, injected three times every other day per week, and the doctor can adjust the dose according to the specific situation of the patient. Usually, the effect is shown after 1-2 months of treatment, and intermittent treatment can be carried out afterwards to achieve long-term remission of the disease. 5. Chronic myeloid leukemia: The recommended dose is 3-9 million international units (IU) injected daily for three months. The doctor can adjust the dose according to the patient's specific situation. After the blood picture is relieved, maintenance treatment can be carried out, with injections every other day. Cytogenetic indicators can be relieved after 9-10 months.

The most common adverse reactions are: fever, chills, fatigue, headache, muscle aches, anorexia and other flu-like symptoms. Taking antipyretic and analgesic drugs (paracetamol, etc.) can alleviate or eliminate these symptoms. These symptoms can also be relieved with continued medication or adjustment of the dosage. Common abnormalities in hematological indicators include leukopenia, thrombocytopenia and increased transaminase.

Patients with a history of allergy to interferon alpha 2b or other ingredients of this preparation, as well as patients with severe liver, kidney and bone marrow dysfunction should not use this product.

Not yet clear

Store at 2-8℃ away from light.

5 million units

Zhejiang Beisheng Pharmaceutical Hansheng Pharmaceutical Co., Ltd.

• Founded in:

  2000-01-28

• Address:

  Jiangbei High-tech Industrial Park, Dongyang City, Zhejiang Province

• Tax NO.:

  913307837176731653

• Registered Funds:

  80 million yuan

• Website:

  Log in to view

• Email:

  Log in to view